심성훈
#유방암의 항암화학요법
|
학력
1998-03~2004-02 서울대학교 의학과 대졸
2007-03~2009-02 서울대학교 의학과 대학원졸(석사)
2012-03~2018-02 서울대학교 의학과 대학원졸(박사)
2007-03~2009-02 서울대학교 의학과 대학원졸(석사)
2012-03~2018-02 서울대학교 의학과 대학원졸(박사)
경력
2004-03~2015-02 서울대학교병원 인턴
2005-03~2009-02 서울대학교병원 레지던트
2009-03~2012-04 국군수도병원 군의관
2012-05~2015-02 서울대학교병원 혈액종양전임의
2015-03~2016-02 국립암센터 유방암센터 임상스텝전문의
2016-03~2019-01 국립암센터 내과 의사직
2016-03~현재 국립암센터 유방암센터 의사직
2018-03~2019-01 국립암센터 암중개연구과 주임연구원
2019-02~현재 국립암센터 암생존자통합지지센터 의사직
2019-02~현재 국립암센터 이행성연구부 선임연구원
2019-02~현재 국립암센터 임상시험센터 의사직
2019-02~현재 국립암센터 혈액종양내과분과 의사직
2019-11~현재 국립암센터 외래주사치료실 실장
2005-03~2009-02 서울대학교병원 레지던트
2009-03~2012-04 국군수도병원 군의관
2012-05~2015-02 서울대학교병원 혈액종양전임의
2015-03~2016-02 국립암센터 유방암센터 임상스텝전문의
2016-03~2019-01 국립암센터 내과 의사직
2016-03~현재 국립암센터 유방암센터 의사직
2018-03~2019-01 국립암센터 암중개연구과 주임연구원
2019-02~현재 국립암센터 암생존자통합지지센터 의사직
2019-02~현재 국립암센터 이행성연구부 선임연구원
2019-02~현재 국립암센터 임상시험센터 의사직
2019-02~현재 국립암센터 혈액종양내과분과 의사직
2019-11~현재 국립암센터 외래주사치료실 실장
논문
2020 SCI-E Discrimination of ascitic fluid infection inmalignant ascites by polymorphonuclear neutrophil ratio and count: Investigating the validity of count ≥250/mm3 as the one-size-fits-all criterion: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. Online:Published (2.012)
2020 SCI-E Supervised Physical Rehabilitation in the Treatment of Patients with Advanced Cancer: a Systematic Review and Meta-analysis: JOURNAL OF KOREAN MEDICAL SCIENCE. 35(29):e242~ (1.705)
2020 SCI-E Cumulative incidence of chemotherapy-induced cardiotoxicity during a 2-year follow-up period in breast cancer patients: BREAST CANCER RESEARCH AND TREATMENT. 182(2):333~343 (3.831)
2020 SCI-E Genome-wide association study of genetic variants related to anthracycline-induced cardiotoxicity in early breast cancer: CANCER SCIENCE. Online:Published (4.966)
2020 SCI-E Reliability and Validity of the Korean Language Version of the U.S. National Cancer Institute's Patient-Reported Outcomes Common Terminology Criteria for Adverse Events: JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 59(5):1082~1088 (3.077)
2019 SCI Genomic characteristics of triple-negative breast cancer nominate molecular subtypes that predict chemotherapy response: Molecular Cancer Research. Online:Published (4.484)
2019 SCI Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16): British journal of cancer. Online:Published (5.416)
2019 SCI Anti-tumor activity of BET inhibitors in androgen-receptor-expressing triple-negative breast cancer.: SCIENTIFIC REPORTS. Online:Published (4.011)
2019 SCI-E Anti-tumor activity of BET inhibitors in androgen-receptor-expressing triple-negative breast cancer: SCIENTIFIC REPORTS. 9(1):13305~ (3.998)
2019 SCI The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial: ANNALS OF SURGICAL ONCOLOGY. 26(8):2409~2416 (3.681)
2019 SCI-E Integrative In Vivo Drug Testing Using Gene Expression Signature and Patient-Derived Xenografts from Treatment-Refractory HER2 Positive and Triple-Negative Subtypes of Breast Cancer: CANCERS. 11(4):E574~E574 (6.162)
2019 SCI-E randomized open label phase III tiral of irinotecan plus capecitabine versus capecitabine monotherapy in patients with metastatic breast cancer previously treated with anthracycline and taxane : PROCEED trial (KCSG BR 11-01): CANCER RESEARCH AND TREATMENT. 51(1):43~52 (3.363)
2018 SCI-E Predicting Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: combined Statistical Modeling Using Clinicopathological Factors and FDG PET/CT Texture Parameters: clinical nuclear medicine. 44(1):21~29 (6.309)
2018 SCI-E Validation of the Clinical Index of Stable Febrile Neutropenia (CISNE) model in febrile neutropenia patients visiting the emergency department. Can it guide emergency physicians to a reasonable decision on outpatient vs. inpatient treatment?: PLOS ONE. 13(12):e0210019~e0210019 (2.766)
2018 SCI-E Magnetic Resonance Imaging (MRI) Assessment of Residual Breast Cancer After Neoadjuvant Chemotherapy: Relevance to Tumor Subtypes and MRI Interpretation Threshold.: Clinical breast cancer. 18(6):459~467 (2.703)
2018 SCI-E Doxorubicin-induced heart failure in cancer patients: A cohort study based on the Korean National Health Insurance Database: CANCER MEDICINE. 7(12):6084~6092 (3.202)
2018 SCI-E Incidence of Diabetes After Cancer Development : A Korean National Cohort Study: JAMA oncology. 4(8):1099~1105 (20.871)
2018 SCI Use of adjuvant chemotherapy in hormone receptor-positive breast cancer patients with or without the 21-gene expression assay: Breast cancer research and treatment. 170(1):69~76 (3.605)
2018 SCI-E Phase I/II clinical trial of everolimus combined with gemcitabine/cisplatin for metastatic triple-negative breast cancer.: Journal of Cancer. 9(7):1145~1151 (3.249)
2017 SCI-E CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer: PLOS ONE. 12(8):e0182107~e0182107 (2.806)
2017 SCI Comprehensive somatic genome alterations of urachal carcinoma: Journal of medical genetics. 54(8):572~578 (5.451)
2017 SCI Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.: Am J Pathol. IN:PRINT (4.206)
2016 SCI-E A Rare Case of Phyllodes Tumor Metastasis to the Stomach Presenting as Anemia: Cancer research and treatment. Online:Published (4.245)
2016 SCI-E Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.: BMC Cancer.. Online:Published (3.362)
2015 SCI-E Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors: Thoracic Cancer. 7(2):161~166 (0.898)
2015 SCI-E Gefitinib-induced Interstitial Lung Disease in Korean Lung Cancer Patients: Cancer research and treatment. 48(1):88~97 (3.318)
2015 SCI Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancer: Journal of cancer research and clinical oncology. 141(6):1073~1081 (3.081)
2015 SCI-E Gefitinib-induced Interstitial Lung Disease in Korean Lung Cancer Patients: Cancer research and treatment. Online:Published (3.318)
2014 SCI The effect of gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer: Journal of cancer research and clinical oncology. 140(12):2135~2142 (3.009)
2014 SCI Prediction of survival in terminally ill cancer patients at the time of terminal cancer diagnosis: Journal of cancer research and clinical oncology. 140(9):1567~1574 (3.009)
2014 SCI-E p21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer: BMC cancer [electronic resource]. 14:241~241 (3.319)
2013 기타 A case of meningococcal sepsis and meningitis with complement 7 deficiency in a military trainee Infect Chemother: Infect Chemother. 45(1):94~98 ()
2013 기타 Application of cancer genomics to solve unmet clinical needs: Genomics Inform. 11(4):174~179 ()
2012 SCI Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancer: Cancer Sci. 103(2):155~160 (3.534)
2009 SCI Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma. Lung Cancer: Lung Cancer. 65(2):204~207 (3.737)
2009 SCI-E The role of PET/CT in detection of gastric cancer recurrence: BMC Cancer. 1:73~73 (3.32)
2020 SCI-E Supervised Physical Rehabilitation in the Treatment of Patients with Advanced Cancer: a Systematic Review and Meta-analysis: JOURNAL OF KOREAN MEDICAL SCIENCE. 35(29):e242~ (1.705)
2020 SCI-E Cumulative incidence of chemotherapy-induced cardiotoxicity during a 2-year follow-up period in breast cancer patients: BREAST CANCER RESEARCH AND TREATMENT. 182(2):333~343 (3.831)
2020 SCI-E Genome-wide association study of genetic variants related to anthracycline-induced cardiotoxicity in early breast cancer: CANCER SCIENCE. Online:Published (4.966)
2020 SCI-E Reliability and Validity of the Korean Language Version of the U.S. National Cancer Institute's Patient-Reported Outcomes Common Terminology Criteria for Adverse Events: JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 59(5):1082~1088 (3.077)
2019 SCI Genomic characteristics of triple-negative breast cancer nominate molecular subtypes that predict chemotherapy response: Molecular Cancer Research. Online:Published (4.484)
2019 SCI Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16): British journal of cancer. Online:Published (5.416)
2019 SCI Anti-tumor activity of BET inhibitors in androgen-receptor-expressing triple-negative breast cancer.: SCIENTIFIC REPORTS. Online:Published (4.011)
2019 SCI-E Anti-tumor activity of BET inhibitors in androgen-receptor-expressing triple-negative breast cancer: SCIENTIFIC REPORTS. 9(1):13305~ (3.998)
2019 SCI The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial: ANNALS OF SURGICAL ONCOLOGY. 26(8):2409~2416 (3.681)
2019 SCI-E Integrative In Vivo Drug Testing Using Gene Expression Signature and Patient-Derived Xenografts from Treatment-Refractory HER2 Positive and Triple-Negative Subtypes of Breast Cancer: CANCERS. 11(4):E574~E574 (6.162)
2019 SCI-E randomized open label phase III tiral of irinotecan plus capecitabine versus capecitabine monotherapy in patients with metastatic breast cancer previously treated with anthracycline and taxane : PROCEED trial (KCSG BR 11-01): CANCER RESEARCH AND TREATMENT. 51(1):43~52 (3.363)
2018 SCI-E Predicting Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: combined Statistical Modeling Using Clinicopathological Factors and FDG PET/CT Texture Parameters: clinical nuclear medicine. 44(1):21~29 (6.309)
2018 SCI-E Validation of the Clinical Index of Stable Febrile Neutropenia (CISNE) model in febrile neutropenia patients visiting the emergency department. Can it guide emergency physicians to a reasonable decision on outpatient vs. inpatient treatment?: PLOS ONE. 13(12):e0210019~e0210019 (2.766)
2018 SCI-E Magnetic Resonance Imaging (MRI) Assessment of Residual Breast Cancer After Neoadjuvant Chemotherapy: Relevance to Tumor Subtypes and MRI Interpretation Threshold.: Clinical breast cancer. 18(6):459~467 (2.703)
2018 SCI-E Doxorubicin-induced heart failure in cancer patients: A cohort study based on the Korean National Health Insurance Database: CANCER MEDICINE. 7(12):6084~6092 (3.202)
2018 SCI-E Incidence of Diabetes After Cancer Development : A Korean National Cohort Study: JAMA oncology. 4(8):1099~1105 (20.871)
2018 SCI Use of adjuvant chemotherapy in hormone receptor-positive breast cancer patients with or without the 21-gene expression assay: Breast cancer research and treatment. 170(1):69~76 (3.605)
2018 SCI-E Phase I/II clinical trial of everolimus combined with gemcitabine/cisplatin for metastatic triple-negative breast cancer.: Journal of Cancer. 9(7):1145~1151 (3.249)
2017 SCI-E CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer: PLOS ONE. 12(8):e0182107~e0182107 (2.806)
2017 SCI Comprehensive somatic genome alterations of urachal carcinoma: Journal of medical genetics. 54(8):572~578 (5.451)
2017 SCI Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.: Am J Pathol. IN:PRINT (4.206)
2016 SCI-E A Rare Case of Phyllodes Tumor Metastasis to the Stomach Presenting as Anemia: Cancer research and treatment. Online:Published (4.245)
2016 SCI-E Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.: BMC Cancer.. Online:Published (3.362)
2015 SCI-E Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors: Thoracic Cancer. 7(2):161~166 (0.898)
2015 SCI-E Gefitinib-induced Interstitial Lung Disease in Korean Lung Cancer Patients: Cancer research and treatment. 48(1):88~97 (3.318)
2015 SCI Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancer: Journal of cancer research and clinical oncology. 141(6):1073~1081 (3.081)
2015 SCI-E Gefitinib-induced Interstitial Lung Disease in Korean Lung Cancer Patients: Cancer research and treatment. Online:Published (3.318)
2014 SCI The effect of gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer: Journal of cancer research and clinical oncology. 140(12):2135~2142 (3.009)
2014 SCI Prediction of survival in terminally ill cancer patients at the time of terminal cancer diagnosis: Journal of cancer research and clinical oncology. 140(9):1567~1574 (3.009)
2014 SCI-E p21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer: BMC cancer [electronic resource]. 14:241~241 (3.319)
2013 기타 A case of meningococcal sepsis and meningitis with complement 7 deficiency in a military trainee Infect Chemother: Infect Chemother. 45(1):94~98 ()
2013 기타 Application of cancer genomics to solve unmet clinical needs: Genomics Inform. 11(4):174~179 ()
2012 SCI Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancer: Cancer Sci. 103(2):155~160 (3.534)
2009 SCI Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma. Lung Cancer: Lung Cancer. 65(2):204~207 (3.737)
2009 SCI-E The role of PET/CT in detection of gastric cancer recurrence: BMC Cancer. 1:73~73 (3.32)
저서
저서 내용이 없습니다.
보도자료
표적항암제 쓰려고 난소절제 권고받는 유방암 환자들
http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1134683&REFERER=NP
http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1134683&REFERER=NP
포스팅
포스팅 내용이 없습니다.
영상자료
발표자료
발표자료 내용이 없습니다.